1 In a previous study, we attempted to verify the classification of 5-hydroxytryptamine2 (5-HT2) receptors in three vascular tissues, by use of the conventional antagonists, ketanserin, spiperone, methysergide and trazodone. However, it was not possible to conclude homogeneity of the receptor type in the three tissues due to the inconsistent behaviour of these antagonists, in particular, their apparently variable affinities between the tissues. These results led to the reliability of the conventional antagonists being questioned as receptor probes. 2 In the present study, a set of tryptamine analogues were investigated in two of the tissues, the rabbit aorta and the rat jugular vein. Unlike the conventional antagonists, these compounds bear a close chemical relation to the natural agonist, 5-HT. 3 In both tissues, ac,x-dimethyltryptamine demonstrated apparently simple competitive antagonism of 5-HT-induced constrictions. Its affinity was estimated to be the same in each case. 4 The affinities and relative efficacies of 5-HT, 5-cyanotryptamine, N,N-dimethyltryptamine and Nbenzyl-5-methoxytryptamine were also found to be indistinguishable between the two tissues. 5 Unlike the conventional 5-HT2 receptor antagonists, these tryptamine analogues failed to distinguish between the 5-HT receptors in the rabbit aorta and rat jugular vein implying that they truly belong to the same class. In view of this result, it is suggested that simple tryptamine analogues are more reliable probes for 5-HT receptor classification than ligands which bear little or no chemical relation to the natural agonist.
Introduction
In a previous study we investigated the effects of some standard 5-hydroxytryptamine (5-HT) antagonists, ketanserin, trazodone, methysergide and spiperone in three isolated vascular preparations. Each of the tissues used had been claimed to contain 5-HT2 receptors (Leysen et al., 1982; Humphrey et al., 1982; Cohen et al., 1983; Maayani et al., 1984) and the object of the study was to examine the extent to which this classification could be substantiated quantitatively. Applying the established criteria for the pharmacological analysis of antagonism (Schild, 1973; we found that only spiperone and trazodone behaved as simple competitive antagonists in every tissue. However, affinity estimates for trazodone varied between the tissues by over an order of magnitude and smaller but significant discrepancies were also noted for spiperone.
Although ketanserin produced surmountable competitive antagonism in two of the three tissues it too expressed significantly different affinities in these cases. The non-surmountable type of antagonism obtained with ketanserin in the third tissue was also obtained with methysergide in two of the three tissues used.
The variable effects of these antagonists meant that the receptors in the different tissues could not be reliably classified. The data involving non-surmountable antagonism could not contribute meaningful information towards receptor classification and the variable affinities expressed by the same antagonist could be interpreted either as evidence for receptor heterogeneity or as an indication that the antagonists used were inadequate receptor probes. The latter argument would imply that the antagonists interact with binding sites in the receptor which are accessory to those with which the natural agonist, 5-HT, interacts. These accessory sites could vary between the different tissues (Ariens et al., 1979; Kenakin, 1984) .
In an attempt to resolve this question we have now studied a series of tryptamine analogues which, unlike the antagonists used previously, retain a close chemical relation to the natural agonist. The object of the study was to determine whether such compounds would provide more meaningful information for the classification of the receptors in question.
Methods

Vascular tissue preparations
Rabbit aorta: The thoracic aorta was removed from male New Zealand white rabbits (2.0-2.5 kg) which had been killed by injection of pentobarbitone sodium (Sagatal: 60mg kg-') into a marginal ear vein. The vessel was cleared of adhering connective tissue after mounting on a polypropylene cannula (external diameter = 2.5 mm). For each experiment, six ring segments, approximately 3 mm wide, were prepared as described by Stollak & Furchgott (1983) , preserving the plane of the circular smooth muscle. (Innes, 1962; Apperley et al., 1976; Fozard & Mwaluko, 1976; Marin et al., 1981) . At the end of the stabilization period, the inhibitors were removed by several exchanges of the organ bath Krebs solution. Tissues were then challenged with a nearmaximally effective concentration of 5-HT (rabbit aorta 0I pM, rat jugular vein 1 pM) to establish viability. Also, in antagonism experiments, this treatment provided a reference contraction by which subsequent responses could be normalized.
In six replicate antagonist experiments with a,adimethyltryptamine, tissues were exposed to drug or the vehicle for 60 min before the construction of a 5-HT concentration-effect (E/[A]) curve. In a single experiment each of the six vascular ring preparations were treated with different concentrations, including zero, of the antagonist. Therefore replicate numbers and errors refer to the number of preparations. When the agonists 5-HT, 5-cyanotryptamine, N,N-dimethyltryptamine and N-benzyl-5-methoxytryptamine were studied in four experiments, single E/[A] curves were obtained in different preparations; two additional 5-HT E/[A] curves were obtained at the same time in tissues previously exposed for 30 min to phenoxybenzamine (rabbit aorta: 5 x 10-8M and 10-7M; rat jugular vein: 10-8 M and 2 x 10-8 M). Thus, each of the six ring segments was treated with a different agonist or subjected to phenoxybenzamine treatment. As with antagonism experiments, replicate numbers for each condition refer to the number of preparations used. The concentration of agonist in the organ bath was always increased cumulatively in 0.5 logl0 unit increments. Black et al., 1985; Barrett et al., 1986 ):
Analysis of data
in which KA is the agonist dissociation constant, T is the efficacy of the agonist in a particular tissue, Em is the maximum possible effect in the receptor system and n determines the sensitivity of the occupancyeffect relation.
four separate experiments.
The lines drawn through the data were produced by fitting both sets of data simultaneously to the operational model using equation (3), assuming that the same value of KA and the same relative value of T could be estimated for each agonist in the two tissues, in other words, assuming that the receptors in the two tissues were of the same type. The maximum possible response, Em, and n, the sensitivity of the occupancyeffect, E/[AR], relation were assumed to be tissuedependent. In order to estimate KA and Tfor partial agonists it is necessary that Em be known Leff et al., 1985; Leff, 1986 method (1966) ofirreversible antagonism is applied to partial agonists. As shown previously (Black et al., 1985; Barrett et al., 1986 ) 5-HT itself acts as a partial agonist in the rabbit aorta and Em, must be estimated in this system. Therefore, Furchgott's method was applied in this study. The effects of phenoxybenzamine on 5-HT responses were measured in each tissue and the resulting E/[A] curves were fitted simultaneously with those of the other agonists. For clarity, the phenoxybenzamine-treatment data are shown separately in Figure 2 . The results demonstrate that in the ratjugular vein as well as the rabbit aorta, 5-HT behaves partially.
Estimates of pKA and r for each agonist together with estimates of Em and n in each tissue are shown in Table 1 . Comparison of the data with the fitted lines in Figure 1 indicates that the assumption of receptor homogeneity in the two tissues was reasonable. Separate analyses of the data shown in Figure 2 
Analysis of antagonism
The tryptamine analogue, x,-dimethyltryptamine, which showed no agonism in either preparation, was analysed as an antagonist of 5-HT. In both tissues, this compound produced parallel displacements of E/ [A] curves (Figures 3a and b) . Analysis of computed [Am] values by equation (2) gave estimates of n (equivalent to the Schild plot slope) of 0.97 ± 0.03 in the rabbit aorta and 1.00 ± 0.04 in the rat jugular vein. Each estimate was not significantly different from unity.
The estimated pKB values (estimated with n constrained to unity) were 5.67 ± 0.16 in the rabbit aorta and 5.53 ± 0.07 in the rat jugular vein. These two estimates were not significantly different. The effect of C,a-dimethyltryptamine on computed [Ao] values is shown for each tissue in the form of Clark plots (Figures 3c and d) . 
Discussion
In our previous study ) the classification of 5-HT receptors in three different vascular tissues was made equivocal because of variable qualitative and quantitative effects of the putative 5-HT2-receptor antagonists used. In this study we used some simple analogues of tryptamine to re-examine the classification of 5-HT receptors in two of these tissues, the rabbit aorta and rat jugular vein. The results obtained with agonist and antagonist analogues demonstrate that the 5-HT receptors in these two tissues are quantitatively indistinguishable. agonist was about 1.5 times more 'efficacious' in the jugular vein preparation than in the rabbit aorta (Table 1) . This difference can be explained by a higher functional receptor concentration in the former tissue compared with the latter and/or a more efficient transducer system Kenakin, 1984) . The present results contradict those previously obtained with the antagonists ketanserin, spiperone and trazodone, each of which displayed variable affinities for the receptors in question . Whereas the previous data allowed two possible interpretations, namely, dissimilarity between the receptors or unreliability of the antagonists as probes, the present data permit only one conclusion, that is, receptor homogeneity. The use of agonists as well as a competitive antagonist in the present study lends weight to this conclusion since it is based on efficacy and affinity information and not merely the latter.
Since, evidently, the chemical interactions between the tryptamine analogues and the receptors in each tissue appear to be the same, as judged by affinity and efficacy, but the affinities of the conventional 5-HT2- (Bradley et al., 1983) ; rat caudal artery (8.8) (Bradley et al., 1983) ; bovine coronary artery (9.2) (Kaumann, 1983) ; rat portal vein (9.7) (Lemberger et al., 1984) ; rat femoral artery (10.4) (Mecca & Webb, 1984) . In the authors' opinion, such subtyping serves no genuine purpose in pharmacological classification as it tends to create disorder rather than order. By implication the definition of the term 'receptor' upon which it is based must be regarded as too plastic.
If, as we prefer, the term is reserved for sites at which hormones and transmitters act in physiologically intact systems then the receptors in the present study would be classified as the same. Adopting Stephenson's definition of a receptor (Stephenson, 1975) , namely 'that small spatial arrangement of atoms to which a substance endogeneous to the organism attaches itself as an essential step in modifying cellular functions', subtyping of receptors would only be possible when there is evidence that the chemical information in a hormone is processed differently by different sites. As well as being more conservative, this definition and the tests for receptor homogeneity or heterogeneity that it entails, provides a means of understanding the ways in which physiological systems are ordered. This must be one of the objects of pharmacological classification.
